Clonal CD8+ T-cell expansion is associated with complete response to elranatamab in refractory multiple myeloma

Clonal CD8⁺ T-cell expansion is associated with complete response to elranatamab in refractory multiple myeloma

Haematologica. 2024 Sep 1;109(9):3078-3080. doi: 10.3324/haematol.2023.284942.

¹ Clinical Immunology Laboratory, Groupe Hospitalier Universitaire Paris Saclay, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Le-Kremlin-Bicêtre, France; UMR 996 INSERM, Inflammation Microbiome and Immunosurveillance, Paris-Saclay University, Orsay.
² Department of Rheumatology, Université Paris Saclay, FHU CARE, INSERM UMR1184, APHP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; Paris-Saclay University, Faculty of Medicine, INSERM, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin-Bicêtre.
³ Clinical Immunology Laboratory, Groupe Hospitalier Universitaire Paris Saclay, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Le-Kremlin-Bicêtre, France; Université Paris Cité, CNRS, INSERM, UTCBS, Unité des technologies Chimiques et Biologiques pour la Santé, Paris.
⁴ Department of Rheumatology, Université Paris Saclay, FHU CARE, INSERM UMR1184, APHP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; Paris-Saclay University, Faculty of Medicine, INSERM, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin-Bicêtre. [email protected].

No abstract available

Funding: Funding was provided by FHU CARE.